Literature DB >> 18505733

The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex.

Vaishali R Moulton1, Vasileios C Kyttaris, Yuang-Taung Juang, Bhabadeb Chowdhury, George C Tsokos.   

Abstract

T cell dysfunction is crucial to the pathogenesis of systemic lupus erythematosus (SLE); however, the molecular mechanisms involved in the deficient expression of the T cell receptor-associated CD3zeta chain in SLE are not clear. SLE T cells express abnormally increased levels of an alternatively spliced isoform of CD3zeta that lacks a 562-bp region in its 3'-untranslated region (UTR). We showed previously that two adenosine/uridine-rich elements (ARE) in this splice-deleted region of CD3zeta transcript are critical for the mRNA stability and protein expression of CD3zeta. In this study we show for the first time that the mRNA-stabilizing protein HuR binds to these two ARE bearing regions of CD3zeta 3'-UTR. Knockdown of HuR resulted in decreased expression of the CD3zeta chain, whereas overexpression led to the increase of CD3zeta chain levels. Additionally, overexpression of HuR in human T cells resulted in increased mRNA stability of CD3zeta. Our results identify the 3'-UTR of CD3zeta as a novel target for the mRNA-stabilizing protein HuR. Thus, the absence of two critical AREs in the alternatively spliced CD3zeta 3'-UTR found in SLE T cells may result in decreased HuR binding, representing a possible molecular mechanism contributing to the reduced stability and expression of CD3zeta in SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505733      PMCID: PMC2459291          DOI: 10.1074/jbc.M710434200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE.

Authors:  George C Tsokos; Madhusoodana P Nambiar; Klaus Tenbrock; Yuang-Taung Juang
Journal:  Trends Immunol       Date:  2003-05       Impact factor: 16.687

Review 2.  HuR in the mammalian genotoxic response: post-transcriptional multitasking.

Authors:  Myriam Gorospe
Journal:  Cell Cycle       Date:  2003 Sep-Oct       Impact factor: 4.534

3.  Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs.

Authors:  Ashish Lal; Krystyna Mazan-Mamczarz; Tomoko Kawai; Xiaoling Yang; Jennifer L Martindale; Myriam Gorospe
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

4.  Identification of a target RNA motif for RNA-binding protein HuR.

Authors:  Isabel López de Silanes; Ming Zhan; Ashish Lal; Xiaoling Yang; Myriam Gorospe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

5.  The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells.

Authors:  Sandeep Krishnan; Vishal G Warke; Madhusoodana P Nambiar; George C Tsokos; Donna L Farber
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

6.  Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.

Authors:  Madhusoodana P Nambiar; Carolyn U Fisher; Vishal G Warke; Sandeep Krishnan; Jeanne P Mitchell; Nancy Delaney; George C Tsokos
Journal:  Arthritis Rheum       Date:  2003-07

7.  Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus.

Authors:  Vasileios C Kyttaris; Yuang-Taung Juang; Klaus Tenbrock; Arthur Weinstein; George C Tsokos
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

8.  Identification of RNA-binding proteins in RAW 264.7 cells that recognize a lipopolysaccharide-responsive element in the 3-untranslated region of the murine cyclooxygenase-2 mRNA.

Authors:  Steven J Cok; Stephen J Acton; Alison E Sexton; Aubrey R Morrison
Journal:  J Biol Chem       Date:  2003-12-08       Impact factor: 5.157

9.  Role of the RNA-binding protein HuR in colon carcinogenesis.

Authors:  Isabel López de Silanes; Jinshui Fan; Xiaoling Yang; Alan B Zonderman; Olga Potapova; Ellen S Pizer; Myriam Gorospe
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

10.  Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.

Authors:  Carsten Denkert; Wilko Weichert; Sören Pest; Ines Koch; Dirk Licht; Martin Köbel; Angela Reles; Jalid Sehouli; Manfred Dietel; Steffen Hauptmann
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

View more
  19 in total

Review 1.  Post-transcriptional coordination of immunological responses by RNA-binding proteins.

Authors:  Panagiota Kafasla; Antonis Skliris; Dimitris L Kontoyiannis
Journal:  Nat Immunol       Date:  2014-06       Impact factor: 25.606

2.  Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site.

Authors:  Kamalpreet Nagpal; Katsue Sunahori Watanabe; Betty P Tsao; George C Tsokos
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

3.  Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.

Authors:  Takayuki Katsuyama; Hao Li; Denis Comte; George C Tsokos; Vaishali R Moulton
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

4.  Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity.

Authors:  José C Crispín; Brendan T Keenan; Michele D Finnell; Bonnie L Bermas; Peter Schur; Elena Massarotti; Elizabeth W Karlson; Lisa M Fitzgerald; Sukran Ergin; Vasileios C Kyttaris; George C Tsokos; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2010-05

5.  Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

Review 6.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

7.  Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells.

Authors:  Vaishali R Moulton; Andrew R Gillooly; George C Tsokos
Journal:  J Biol Chem       Date:  2013-12-24       Impact factor: 5.157

8.  Conditional knockout of the RNA-binding protein HuR in CD4⁺ T cells reveals a gene dosage effect on cytokine production.

Authors:  Matthew M Gubin; Patsharaporn Techasintana; Joseph D Magee; Garrett M Dahm; Robert Calaluce; Jennifer L Martindale; Maryln S Whitney; Craig L Franklin; Cindy Besch-Williford; John W Hollingsworth; Kotb Abdelmohsen; Myriam Gorospe; Ulus Atasoy
Journal:  Mol Med       Date:  2014-03-20       Impact factor: 6.354

9.  Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus.

Authors:  Takayuki Katsuyama; Ignacio Juarez Martin-Delgado; Suzanne M Krishfield; Vasileios C Kyttaris; Vaishali R Moulton
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

10.  Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis.

Authors:  Takayuki Katsuyama; Hao Li; Suzanne M Krishfield; Vasileios C Kyttaris; Vaishali R Moulton
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.